CATALENT XPRESS PHARMACEUTICS

Live / Registered — Registered (as of 21 Mar 2023)

What this means for you

Registered since 21 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97596774
Registration number
7006423
Mark type
Stylized text
Filed
19 Sept 2022
Published for opposition
03 Jan 2023
Registered
21 Mar 2023
Attorney of record
Vanessa A. Ignacio, Esq.

Goods and services

  • Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; Manufacturing process consulting
  • Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of oral drug formulations and drug dosage for clinical studies; Scientific and technological services, namely, scientific research, analysis, and clinical testing in the field of pharmaceuticals, biopharmaceuticals, oral drug formulations and drug dosage; Scientific research and development; Consulting services for others in the field of designing clinical trials

Owner

Prior registrations

Prosecution history

  • 15 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 15 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 15 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 15 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 15 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 18 Sept 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 21 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 21 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
  • 03 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 03 Jan 2023 — PUBLISHED FOR OPPOSITION
  • 14 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 29 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 28 Nov 2022 — EXAMINER'S AMENDMENT ENTERED
  • 28 Nov 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 28 Nov 2022 — EXAMINERS AMENDMENT E-MAILED

View this trademark record on Marksy